Defense Advanced Research Project Agency - Deep Bleeder Acoustic Coagulation (DBAC)

The summary for the Defense Advanced Research Project Agency - Deep Bleeder Acoustic Coagulation (DBAC) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.

Defense Advanced Research Project Agency - Deep Bleeder Acoustic Coagulation (DBAC): Announcement of Federal Funding Opportunity Summary I. GENERAL INFORMATION A. Program Name: Defense Advanced Research Project Agency Deep Bleeder Acoustic Coagulation(DBAC) B. Funding Opportunity Number: DARPA05-01DBAC C. Agency Name: Defense Advanced Research Projects Agency 3701 North Fairfax Drive Arlington, VA 22203-1714 D. Agency Contact(s): Mr. Thomas McCreery 1. Questions related to the Program, proposal format, or required documentation may be addressed to DARPA at: Phone: 703-248-1517 Fax: 703-516-7360 E-mail: [email protected] Mail: Defense Advanced Research Projects Agency 3701 North Fairfax Drive Arlington, VA 22203-1714 E. Anticipated Instrument Type(s): Contracts, Grants/Cooperative Agreements and Other Transaction Agreements. F. Catalog of Federal Domestic Assistance (CFDA) Number(s): 12.420; Military Medical Research and Development. G. Award/Regulatory Approval: Once an award is made, the applicant may not use, employ, or subcontract for the use of any human subjects, human anatomical substances/cadavers, or laboratory animals without written permission from the applicable USAMRMC regulatory office. The applicable USAMRMC regulatory office will forward these written approvals directly to the applicant. II. FUNDING OPPORTUNITY DESCRIPTION Extremity wounds predominate on todays battlefield because the torso is protected by the ballistic vest. Blood loss from extremity wounds is the number one cause of preventable battlefield death today (Infantry Magazine, 2004). Loss of blood causes soldiers to enter hemorrhagic shock. There are three stages of shock due to loss of blood: non-progressive shock in which the body can respond and survive without treatment; progressive shock, in which shock becomes progressively worse and death will occur without treatment; and irreversible shock, which leads to death. The goal of the DBAC program is to stop bleeding quickly enough to prevent the transition from non-progressive shock to progressive shock, which occurs when the soldier loses 25% of his blood volume. III. ELIGIBILITY INFORMATION Applicants: Independent investigators at all academic levels (or equivalent) are eligible to submit proposals. All individuals, regardless of ethnicity, nationality, or citizenship status, may apply as long as they are employed by, or affiliated with, an eligible institution. Institutions: Eligible institutions include for-profit, non-profit, public, and private organizations. Other Eligibility Criteria: Please see the Full Text of Program Announcement description for details regarding duplicate submissions, applications from Historically Black Colleges and Universities/Minority Institutions (HBCU/MI), and administrative compliance issues. IV. PROPOSAL PREPARATION AND SUBMISSION INFORMATION A. Proposal Information: Applicants must submit an original (paper) proposal consisting of Volumes I and II, five (5) paper copies and an electronic copy on one of the following types of approved fixed media: a single CD-ROM; a single 100 Megabyte (MB) Iomega Zip disk; or a single 3.5 inch High Density MS-DOS formatted 1.44 MB diskette. Further instructions are provided in Section IV. B. Submission Date and Time: Deadline: July 14, 2005. Proposals must be received by 1600 EST (4:00 PM EST) at Schafer Corporation, 3811 N. Fairfax Drive, Arlington, VA 22203, ATTN: Mr. Larry Dobbs/DARPA05-01DBAC/Document Control V. PROPOSAL EVALUATION Evaluation of the DBAC proposals will be performed using the following criteria, which are listed in descending order of relative importance: a) Scientific and technical merit b) Offeror qualifications c) Cost realism VI. AWARD ADMINISTRATION INFORMATION A. Award Notices and Administrative Requirements: Details of award notification procedures and administrative requirements including regulatory documents (Certificate of Environmental Compliance, Research Involving Human Subjects and/or Anatomical Substances, Research Involving Animals, and Safety Program Plan) can be found in the Full Text of Program Announcement. B. Reporting Requirements: Performers will provide monthly status reports, quarterly reports and a final report at the end of each phase. The Full Text of Program Announcement # DARPA05-01DBAC may be viewed at: http://www.usamraa.army.mil/pages/Baa_Paa/DBAC/DBAC_PA_050526.doc.